advertisement

WGA Rescources

Weinreb RN 37

Showing records 1 to 25 | Display all abstracts from Weinreb RN

75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Weinreb RN
Journal of Glaucoma 2018; 27: 7-15
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Garg A
American Journal of Ophthalmology 2018; 187: 92-98
75420 Anterior Segment Dimensions Following Laser Iridotomy in Acute Primary Angle Closure and Fellow Eyes
Moghimi S
American Journal of Ophthalmology 2018; 186: 59-68
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Mundae RS
American Journal of Ophthalmology 2018; 186: 89-95
75427 Diurnal Variation of Optical Coherence Tomography Measurements of Static and Dynamic Anterior Segment Parameters
Xu BY
Journal of Glaucoma 2018; 27: 16-21
75362 Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss
Yarmohammadi A; Zangwill LM
Ophthalmology 2018; 125: 578-587
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Zangwill LM
American Journal of Ophthalmology 2018; 186: 89-95
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
De Moraes CG
American Journal of Ophthalmology 2018; 187: 92-98
75420 Anterior Segment Dimensions Following Laser Iridotomy in Acute Primary Angle Closure and Fellow Eyes
Bijani F
American Journal of Ophthalmology 2018; 186: 59-68
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Liebmann JM
Journal of Glaucoma 2018; 27: 7-15
75427 Diurnal Variation of Optical Coherence Tomography Measurements of Static and Dynamic Anterior Segment Parameters
Penteado RC
Journal of Glaucoma 2018; 27: 16-21
75420 Anterior Segment Dimensions Following Laser Iridotomy in Acute Primary Angle Closure and Fellow Eyes
Chen R
American Journal of Ophthalmology 2018; 186: 59-68
75427 Diurnal Variation of Optical Coherence Tomography Measurements of Static and Dynamic Anterior Segment Parameters
Weinreb RN
Journal of Glaucoma 2018; 27: 16-21
75362 Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss
Manalastas PIC
Ophthalmology 2018; 125: 578-587
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Cioffi GA
American Journal of Ophthalmology 2018; 187: 92-98
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Kabbara SW
American Journal of Ophthalmology 2018; 186: 89-95
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Martin KR; Kaufman PL
Journal of Glaucoma 2018; 27: 7-15
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Hammel N
American Journal of Ophthalmology 2018; 186: 89-95
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Girkin CA
American Journal of Ophthalmology 2018; 187: 92-98
75420 Anterior Segment Dimensions Following Laser Iridotomy in Acute Primary Angle Closure and Fellow Eyes
Yasseri M
American Journal of Ophthalmology 2018; 186: 59-68
75362 Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss
Fuller NJ
Ophthalmology 2018; 125: 578-587
75246 A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects
Bowd C
American Journal of Ophthalmology 2018; 186: 89-95
75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Medeiros FA
American Journal of Ophthalmology 2018; 187: 92-98
75362 Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss
Diniz-Filho A
Ophthalmology 2018; 125: 578-587
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Vittitow JL
Journal of Glaucoma 2018; 27: 7-15

Issue 19-2

Change Issue


advertisement

Oculus